Heartbeam Inc (BEAT)
Official siteHEALTHCARE • HEALTH INFORMATION SERVICES • NASDAQ
Market Cap: $25.04M
Last updated: Nov 17, 2026 at 4:39 PM ET
Heartbeam Inc (BEAT) Statistics
Heartbeam (BEAT) has a market cap of $25.04M and an enterprise value of $18.98M. Its share count is up 66.31% from a year earlier. It holds $6.07M more cash than debt, 24.22% of its market cap.
Total Valuation
Enterprise value is 24.22% below the market cap, as cash exceeds debt.
| Market Cap | $25.04M |
|---|---|
| Enterprise Value | $18.98M |
| Latest price (Nov 17, 2026) | $0.33 |
Key Dates
The next earnings report is expected on Mar 10, 2027, covering the quarter ending Dec 31, 2026.
| Next Earnings Date | Mar 10, 2027 (expected) |
|---|---|
| Last Earnings Date | Nov 12, 2026 |
| Fiscal Year End | December |
Valuation Ratios
| Forward P/S | 67.7x |
|---|---|
| P/B Ratio | 2.9x |
Price Statistics
The stock is down 78.60% over 52 weeks and trades 23.26% below its 50-day average.
| Beta (1Y) | 1.68 |
|---|---|
| 52-Week Change | -78.60% |
| 1-Month Change | -19.18% |
| 3-Month Change | -30.86% |
| 6-Month Change | -63.05% |
| Total Return (1Y) | -78.60% |
| Total Return (3Y CAGR) | -36.43% |
| Total Return (5Y CAGR) | -39.70% |
| Max Drawdown (1Y) | -90.30% |
| Max Drawdown (3Y) | -90.30% |
| Sharpe Ratio (1Y) | -1.06 |
| Correlation with SPY (1Y) | 0.15 |
| 50-Day Average | $0.43 |
| 200-Day Average | $0.78 |
| 52-Week Range | $0.35 to $4.00 |
| RSI (14 Days) | 36.5 |
| Average Volume (20 Days) | 1.27M |
Financial Position
Current assets cover 4.64x current liabilities, and total debt is 0.00x shareholder equity.
| Current Ratio | 4.64x |
|---|---|
| Quick Ratio | 4.55x |
| Debt / Equity | 0.00x |
Returns and Efficiency
Return on equity is -277.11% and return on assets is -229.31% over the last 12 months.
| Return on Equity (ROE) | -277.11% |
|---|---|
| Return on Assets (ROA) | -229.31% |
Scores
BEAT has a Piotroski F-Score of 2 of 9, in the weak band of 0 to 2.
Piotroski F-ScoreWeak at 2 or lessStrong at 8 or more
| Piotroski F-Score | 2 of 9 |
|---|---|
| Piotroski Strength | Weak |
Income Statement
Revenue was $0 over the last 12 months.
| Revenue | $0 |
|---|---|
| Gross Profit | $8.00K |
| Operating Income | -$18.57M |
| Pretax Income | -$18.05M |
| Net Income | -$18.05M |
| EBITDA | -$18.02M |
| Reported EPS (TTM) | -$0.41 |
Trailing 12 months through Sep 30, 2026.
Balance Sheet
Shareholder equity funds 82.72% of the $7.87M in total assets.
| Cash and Equivalents | $6.07M |
|---|---|
| Total Debt | $0 |
| Net Cash | $6.07M |
| Net Cash Per Share | $0.11 |
| Working Capital | $4.94M |
| Shareholder Equity | $6.51M |
| Book Value Per Share | $0.11 |
| Total Assets | $7.87M |
| Total Liabilities | $1.36M |
Balance sheet as of Sep 30, 2026.
Cash Flow
After $980.00K of capital spending, operating cash flow left -$13.43M of free cash flow.
| Operating Cash Flow | -$12.45M |
|---|---|
| Capital Expenditures | $980.00K |
| Free Cash Flow | -$13.43M |
| FCF Per Share | -$0.24 |
| Depreciation and Amortization | $167.00K |
Trailing 12 months through Sep 30, 2026.
Growth
| Book Value Per Share Growth (2Y CAGR) | -64.28% |
|---|---|
| Tangible Book Per Share Growth (2Y CAGR) | -64.28% |
Dividends and Yields
BEAT does not pay a dividend. Its free cash flow yield is -70.31%.
| FCF Yield | -70.31% |
|---|---|
| Buyback Yield | -92.24% |
| Shareholder Yield | -92.24% |
Price Target
Analyst price targets are part of paid GNG plans. See plans
Frequently Asked Questions About BEAT
What is BEAT's market cap?
Heartbeam has a market cap of $25.04M. Its enterprise value, which adds debt and subtracts cash, is $18.98M.
How many shares of BEAT are outstanding?
Heartbeam has 57.20M shares outstanding. The count is up 66.31% from a year earlier.
Does BEAT pay a dividend?
No. Heartbeam does not pay a dividend.
How much debt does BEAT have?
Heartbeam has $0 of total debt and $6.07M of cash and equivalents, a net cash position of $6.07M.
BEAT pages: Overview, Charting, Earnings, Forecast, Financials, Statistics, Competitors